Thrombospondin (TSP) is a trimeric glycoprotein which is synthesized and incorporated into the extracellular matrix by a wide variety of cells. TSP is involved in a number of cellular processes which govern tumor cell behavior including mitogenesis, attachment, migration, and differentiation. To directly assess the role of TSP in tumor cell growth and spread, a human squamous carcinoma cell line, with high TSP production and an invasive phenotype, was transfected with a TSP cDNA antisense expression vector. Five unique transfected clones were obtained with reduced TSP production. Expression of the transfected antisense sequence in these clones was verified by a ribonuclease protection assay. These clones demonstrated reduced growth rates in vitro when compared with a vector transfected control. After subcutaneous inoculation into athymic mice, the antisense clones formed either no tumors or tumors that were slow growing and highly differentiated. This contrasted with the vector-transfected clone which produced poorly differentiated, rapidly growing, invasive tumors. Our results argue in favor of a direct role for TSP in determining the malignant phenotype of certain human tumors. (J. Clin. Invest.
Introduction
The extracellular matrix (ECM)' provides a semisolid support upon which cells attach and adhere. Thrombospondin (TSP), a homotrimeric protein of M, 420 kD, is synthesized by a wide variety of normal and transformed cells and incorporated into the ECM (1) (2) (3) (4) . Functionally, TSP acts as a growth supportive matrix component. TSP has been shown to facilitate cell attachment and serve as an adhesion factor for many cell types (5) (6) (7) (8) (9) . Several converging lines of evidence point to a role for TSP in controlling cellular proliferation. First, TSP mRNA is induced as an immediate early response to growth factor stimu-lation (10) . Second, exogenous TSP potentiates the mitogenic response of epidermal growth factor (EGF) on smooth muscle cells (SMC), and this effect is inhibited by agents which prevent the incorporation of TSP into the matrix (1 1). Third, TSP is found in areas of cellular proliferation in developing mouse embryos (12) . Fourth, TSP is made in significant quantities by proliferating undifferentiated human epidermal keratinocytes (13) , and its production falls in cells induced to differentiate by a variety of means including exposure to high external Ca2" concentrations, exposure to interferon-y or depletion of growth supplements from the culture medium (7, 14) .
In recent studies we have found an inverse correlation between TSP production and degree of in vitro differentiation among several squamous carcinoma cell lines (6) . Because the degree of epithelial tumor cell differentiation is also inversely correlated with malignant behavior, we investigated the possibility that the malignant phenotype of squamous carcinoma cells could be altered by stably lowering TSP levels using antisense RNA. The antisense RNA technique leads to a reduction in the expression of a target gene at the protein level through the formation ofa specific double-stranded RNA hybrid which interferes with normal mRNA transport and translation (15) . This technique has been used successfully to reduce c-fos expression and inhibit 3T3 cell proliferation (16) , to determine the role of the c-myc protooncogene in cell cycle progression and differentiation (17, 18) , and more recently, to investigate the role of the c-raf-1 protooncogene product in conferring radiation sensitivity to a line of human squamous carcinoma cells (19) . In the present study we have constitutively expressed TSP antisense transcripts in a human squamous carcinoma cell line which normally produces high levels of TSP and forms aggressive tumors in nude mice. The antisense clones were analyzed for integration and expression of transfected sequences, TSP production, and in vitro and in vivo growth characteristics. Clones with a reduction in TSP grew at a slower rate in vitro and were less tumorigenic in athymic mice, when compared with parental or vector control lines.
Methods
Vector constructs. The TSP antisense expression plasmid was constructed by isolating the 4.5 kb Xho I fragment containing the entire TSP cDNA from the F2 plasmid (20) and ligating it into the Xho I site ofthe MC CMV expression vector (Fig. 1 , gift ofM. Clarke, University of Michigan). This construction placed the cDNA downstream from and under the transcriptional control of the cytomegalovirus immediate early response promoter and HTLV-1 translational enhancer (21) . The antisense orientation of this new construction was confirmed by restriction endonuclease digestion. The MC CMV expression vector contains the gene-encoding neomycin resistance which enables selection for the presence of this plasmid in mammalian cells using the antibiotic G418 (Geneticin; Sigma Chemical Co., St. Louis, MO). Cell culture. The human squamous carcinoma cell line UM-SCC-1 lB (1 1B) previously described (5, 6) with high TSP production was used for these experiments. The cells were grown in DME supplemented with nonessential amino acids, 2 mM glutamine, 15% FBS, 100 U/ml penicillin, and 100 ,g/ml streptomycin. Cells were maintained at 37°C with 5% CO2 and subcultured by trypsinization.
Transfections. 2 X 107 1 1B cells derived as a subclone ofthe parental line were washed and suspended in 0.5 ml PBS (138 mM NaCl, 2.7 mM KC1, 8.1 mM Na2HPO4, 1.5 mM KH2PO4). 10 Mg of linearized antisense expression plasmid or vector-only DNA was added to the cells which were then electroporated using a Gene Pulser (Bio-Rad Laboratories, Inc., Richmond CA) set at 1.1 kV and 25 MF. After electroporation the cells were suspended in 20 ml of supplemented DME. 48 h after electroporation the cells were subcultured at a 1:10 dilution, and then 24 h later selection was begun in G418 at 400 Mg/ml (Geneticin; Sigma Chemical Co.). G418 resistant clones were individually transferred using filter paper soaked in trypsin and subcultured separately in six-well dishes.
Quantitative immunoprecipitations. Individual transfected clones were grown to 80% confluency in 10-cm dishes and labeled for 6 h with 2 ml cysteine and methionine-free MEM supplemented with 1% BSA and 100 MCi/ml of 35S methionine-cysteine (trans label; ICN Radiochemicals, Irvine, CA). The medium was collected and an equal number of TCA precipitable counts were incubated with rabbit polyclonal anti-TSP antibody overnight at 4°C in the presence of protease inhibitors (1 MLg/ml leupeptin, 1 ,g/ml aprotinin, 10 ,ug/ml soybean trypsin inhibitor, 1 ug/ml pepstatin, and buffer containing 15 mM NaCI, 10 mM NaH2PO4, 1% Triton X-100, 0.5% deoxycholic acid, 0.1% SDS, 20 mM EDTA. The specificity of the anti-TSP antibody has been described previously (12) . Antigen-antibody complexes were precipitated with protein A-Sepharose beads. The pellets were washed and boiled in a sample buffer containing 8 M urea, 50 mM Tris HC1, and 1% SDS, and the eluted proteins resolved on a 7.5% SDS polyacrylamide gel under reducing conditions. After electrophoresis, gels were fixed in methanol and acetic acid, treated with Entensify (New England Nuclear, Boston, MA), dried, and exposed to Kodak XAR film at -80'C. TSP production was quantitated using the Betascope 603 Blot Analyzer (Betagen, Waltham, MA).
Southern analysis. 12 ug of DNA from each clone and the vector transfected control line were cut to completion using Bgl II under conditions suggested by the manufacturer (Boehringer-Mannheim Biochemicals, Mannheim, Germany). Digested DNA was precipitated with linear acrylamide, 0.1 vol 3 M sodium acetate, pH 5.2, and 2 vol of 95% ethanol, electrophoresed on a 0.6% TBE gel, and transferred to a Nytran filter (Schleicher & Schuell, Keene, NH). The filter was hybridized with a PCR generated 32P-labeled fragment of the TSP cDNA at 420C. The filter was washed three times at room temperature in 2x SCC, 0.1% SDS, and once at 650C in 2X SSC, 0.2% SDS. After blotting dry, the filter was exposed to Kodak XAR film at -80'C with an intensifying screen.
Ribonuclease protection assay. Antisense transcript expression was verified using the SP6 riboprobe protocol as previously described (22 RNase A (40 mg/ml) and RNase TI (2 ug/ml; Sigma Chemical Co.). The entire sample was resolved on a 6% polyacrylamide gel. After electrophoresis the gel was dried and exposed to Kodak XAR film at -80'C with an intensifying screen. In vitro and in vivo growth characteristics. In vitro growth rates were determined by plating cells at 7.5 X 104 cells/dish in 35-mm culture dishes. Triplicate dishes ofeach clone were harvested and counted 1-5 d after plating. In vivo growth was assessed by injecting Swiss athymic mice with 1.0 X 10' cells in the hind limb. Animals were examined every other day for signs of tumor growth and tumor size was assessed with a caliper. Animals were sacrificed at 6 wk or when tumors reached a geometric mean diameter of 15-20 mm and sections were taken of the tumor mass and surrounding tissue. After hemotoxylin and eosin staining, sections were examined blindly for degree ofinvasiveness and differentiation.
Results
After transfection of the 11 B squamous carcinoma cell line 12 G4 18 resistant clones were obtained. To ascertain the uniqueness of these clones, we examined the integration site of the transfected plasmid with Southern analysis of genomic DNA cut with Bgl II, which has only a single site in the transfected constructs. Thus, the size ofthe hybridizing fragment is dependent on the distance between the site of random integration of the transfected DNA and the nearest Bgl II recognition sequence in the flanking genomic DNA. A Southern blot containing the Bgl II-digested DNA was probed with a 32P-labeled fragment of the TSP cDNA. This fragment contains a portion of the cDNA which is 3' to the Bgl II recognition site found in the transfected sequence. The group of 12 transfectants contained three uniquely transfected clones. As shown in Fig. 3 We next examined each unique clone for the expression of antisense TSP transcripts. An SP6-generated uniformly labeled RNA sense probe was used for this purpose. As seen in Fig. 3 b, antisense transcripts were identified in all three clones but were absent in the vector-transfected control line.
Immunoprecipitation with a TSP polyclonal antibody was performed to determine TSP production in the transfected clones (12) (Fig. 2 a) . To assess the degree to which TSP production is affected by clonal variation, we analyzed the amount of TSP production in three unique vector control transfected lines by metabolic labeling and subsequent immunoprecipitation. The result of this analysis indicates there is minimal variability (< 5% by scanning densitometry) in TSP production among the transfected clones (Fig. 2 b) .
In vitro growth characteristics are presented in Fig. 4 . All antisense clones showed reduced growth rates when compared with the vector-transfected control. To determine tumorigenicity, we inoculated athymic mice with antisense clones. To strengthen any interpretation resulting from in vivo data, we generated three additional antisense lines in order to have a sufficient number of independent clones assayed for tumorige-*a-345 bp fragment nicity. Characteristics of all clones are summarized in Table I . Similar molecular and biochemical analyses on the additional clones were carried out to verify uniqueness and production of antisense transcript (data not shown). Clones 14 and 10 had a 95% reduction in TSP, whereas clone 8 had a 60% reduction. tumors, whereas three animals injected with this clone produced tumors with a latency greater than the vector control animals. (Fig. 5 ) Grossly the tumors from the vector controls were hemorrhagic without a clear tumor/normal tissue border (Fig. 6 a) .
Histologically, they were poorly differentiated with many mitotic figures and direct extension into the surrounding tissue (Fig. 6 b) . This was in direct contrast to the tumors arising from the antisense clones which grossly were well demarcated from normal tissue, lacked a hemorrhagic appearance (Fig. 6 c) , and histologically were more differentiated, showing development of keratin whorls and pseudoencapsulation (Fig. 6 d) . 
Discussion
Previous studies have established a relationship between TSP production and proliferation in squamous epithelial cells. Histochemically, TSP is localized at sites of rapid proliferation (12) . In squamous epithelium, this includes the basal cell layer and hair follicles (14) . In vitro, undifferentiated, rapidly-proliferating epidermal keratinocytes synthesize large amounts of TSP and incorporate it into the ECM. When the cells are induced to differentiate, TSP production is reduced concomitantly with inhibition ofproliferation (7, 14) . In addition, stimulation of proliferation in quiescent keratinocytes by addition of epidermal growth factor (EGF) or somatomedin C is associated with a rapid induction of TSP synthesis (1 1). Among squamous carcinoma cell lines, there is a direct relationship between proliferation and TSP production (5). Although these data clearly shown that TSP production is associated with proliferation in squamous epithelial cells, cause and effect has not been determined. To address this critical issue, we have, in the present study, utilized antisense-mediated inhibition of TSP synthesis. This approach is a powerful tool for modulating synthesis ofspecific proteins and has been used in the past to investigate the role of oncogenes such as c-fos, c-myc, and c-raf-in the control ofcell proliferation/differentiation (17) (18) (19) 24) . More recently, it has been used to modulate the production of tissue inhibitor of metalloproteinase (TIMP) to study its role in tumor metastasis (25) . Our present work extends this approach to studying a structural component ofthe ECM. In this study we were able to markedly reduce TSP production in squamous carcinoma cells and assess the effect ofthis alteration on the in vitro and in vivo growth. Five unique antisense transfected clones were obtained with reduced production of TSP. The degree to which clonal variation affects TSP production in individual cell lines was determined by assessing TSP levels in three unique vector control lines. Clonal variation in TSP production was < 5% and could not account for the dramatic reduction observed in each antisense clone. The in vitro growth rates were assessed for three of the antisense clones and were shown to correlate with the level of production of TSP in these clones. In vitro growth analysis was not performed on antisense clones 8, 10, and 14 as a consequence of these lines being lost to contamination in tissue culture. In nude mice clones 7, 8, 10, and 14 failed to produce tumors through the duration of the study. Antisense clone No. 12 produced tumors in three out of five animals. These tumors differed from the vector controls by having both a longer latency and slower growth rate. Antisense clone No. 5 had a production ofTSP greater than antisense clone Nos. 7, 8, 10, and 14 but less than antisense No. 12. This clone's in vitro growth rate and tumorigenic potential were similarly interme-diate. Three of the five mice inoculated formed tumors, the latency was longer than antisense clone No. 12 and the tumors failed to reach the geometric mean diameter of the vector controls.
Tumors from the vector control animals were grossly hemorrhagic, had increased mitotic activity and a poorly differentiated phenotype. In contrast, tumors from antisense clone Nos. 12 and 5 showed a highly differentiated phenotype as evidenced by pseudoencapsulation, low mitotic activity, and keratin whorls.
These data are the first to demonstrate that production ofa structural component of the ECM can be modulated by antisense inhibition of protein synthesis. In addition, they provide evidence that doing so alters in vitro and in vivo cell growth behavior. This suggests that TSP plays a functional role in control of cellular proliferation. A similar growth supportive role for TSP has been suggested in mesenchymal cells as discussed earlier (1 1). Thus TSP may serve to modulate growth ofcells of both mesodermal and ectodermal origin. The mechanism by which this occurs is unknown, although it has been shown that endogenously-synthesized TSP serves as a potent adhesion factor for both normal and malignant squamous epithelial cells (5) (6) (7) (8) (9) . By altering the synthesis of this protein, we may have interfered with the capacity of the cells to correctly interact with their matrix and altered their ability to receive and process growth controlling signals. Whereas this is speculation at present, this study provides insight into the importance of TSP in tumorigenesis and emphasizes how any comprehensive theory of cancer biology must address the unique nature of the ECM and its components.
